Skip to main content
Premium Trial:

Request an Annual Quote

Christopher Raimund, Ping Wang, Bernie Bressler, Roger Foxall, Don Riddle, Bob Rieder, Martin Taylor

Premium

Morris, Manning and Martin Adds Wang, Raimund to its Washington, DC, office
 
Intellectual property lawyers Ping Wang and Christopher Raimund have joined the Washington, DC, office of the law firm Morris Manning and Martin as partners.
 
Wang, who will lead the biotechnology practice, previously worked at DLA Piper. She has performed patent work for Chinese and American companies in pharmaceuticals, biotechnology, chemicals, and medical devices. She practiced medicine in China for several years after graduating from Kunming Medical College, then earned her JD degree from Franklin Pierce Law Center in Concord, NH.
 
Raimund, who will lead the firm’s chemical practice, has carried out patent work in the biotechnology, chemical, and materials science areas with technologies that include medical devices, polymers and engineered materials, as well as semiconductor manufacturing and equipment. Raimund was most recently with the Washington, DC, office of Merchant and Gould, and before that worked at DLA Piper, and at the US Patent and Trademark Office as a primary patent examiner. He earned his JD degree from George Washington University and his MSci and BSci degrees from Rensselaer Polytechnic Institute.
 

 
LifeSciences British Columbia Names Winners of its 2008 Awards
 
Five professionals have been named winners of LifeSciences British Columbia’s 10th annual awards:
  • Bernie Bressler and Roger Foxall received lifetime achievement awards. Bressler helped grow the University of British Columbia’s industry liaison office and translational medical research capabilities as VP of research from 1996-99. Last year he was named chairman of Discovery Parks and the Discovery Parks Foundation.

Foxall served Genome British Columbia — one of six government-funded research centers across Canada — as founding president and CEO through 2002, as executive vice president for research, and as executive vice president of corporate development until 2005. Foxall is credited with growing BC’s nascent genomics community, leading to the establishment of Genome BC.

  • Don Riddle, professor in the Michael Smith Laboratories at University of British Columbia, won the Genome BC award for scientific excellence. Riddle helped establish the preliminary framework for sequencing of the nematode, creating the paradigm upon which the human genome sequencing project was modeled.
  • Bob Rieder, the chairman and CEO of the cardiovascular drug development company Cardiome Pharma, won the executive of the year award. Rieder previously served as a vice president at MDS Ventures Pacific in Vancouver, and as a director for nine public and private technology companies.
  • Martin Taylor captured the leadership award. From 1998 to last year, Taylor was the first vice president of research at the University of Victoria. During his tenure, research programs experienced unprecedented growth from $20 million to $100 million. He also joined with Genome BC and Genome Canada to establish a national proteomics platform.
  • LifeSciences British Columbia also honored Pyng Medical Corp. as medical device company of the year; and Lignol Energy Corp. as emerging life sciences company of the year.

    The Scan

    Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

    A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

    Duke University Team Develops Programmable RNA Tool for Cell Editing

    Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

    Novel Gene Editing Approach for Treating Cystic Fibrosis

    Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

    Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

    Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.